Vident Advisory’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,862	Closed	-$41.1K	–	1554
2024 Q4	$41.1K	Sell	10,862 -4,710	-30%	-$17.8K	﹤0.01%	1427
2024 Q3	$50.5K	Buy	15,572 +4,729	+44%	+$15.3K	﹤0.01%	1400
2024 Q2	$20.6K	Buy	+10,843	New	+$20.6K	﹤0.01%	1403